Status:
COMPLETED
An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques
Lead Sponsor:
Merck KGaA, Darmstadt, Germany
Collaborating Sponsors:
Merck Kft., Hungary
Conditions:
Infertility
Eligibility:
FEMALE
Brief Summary
Human gonadotrophins have been successfully used for the treatment of infertility for more than 30 years. This observational study is being conducted to evaluate the efficacy and safety of the gonadot...
Detailed Description
The objective of this observational program is to evaluate the efficacy and safety of the gonadotropins used for COS in ART. The clinical use of the various progesterone preparations will also be moni...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- This is a registry wherein data will be collected from all subjects stimulated by FSH, with- or without down regulation and exogenous luteinising hormone (LH) supplementation, and final follicular maturation triggered by hCG and luteal phase support by any means for controlled ovarian stimulation (COS) in assisted reproductive technique (ART) and intracytoplasmic sperm injection (ICSI).
Exclusion
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
10103 Patients enrolled
Trial Details
Trial ID
NCT01149070
Start Date
June 1 2009
End Date
December 1 2013
Last Update
September 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaáli Institute
Budapest, Istenhegyi Út 54/A, Hungary, 1125